Mouse CCL20/MIP-3 alpha Antibody Summary
Ala28-Met97
Accession # O89093
Applications
Please Note: Optimal dilutions should be determined by each laboratory for each application. General Protocols are available in the Technical Information section on our website.
Scientific Data
Detection of Mouse CCL20 by Western Blot. Western blot shows lysates of mouse small intestine. PVDF membrane was probed with 2 µg/mL of Mouse CCL20/MIP-3a Monoclonal Antibody (Catalog # MAB760) followed by HRP-conjugated Anti-Rat IgG Secondary Antibody (Catalog # HAF005). A specific band was detected for CCL20 at approximately 10 kDa (as indicated). This experiment was conducted under reducing conditions and using Immunoblot Buffer Group 1.
Detection of Mouse CCL20/MIP-3 alpha by Western Blot Conditional macrophage ablation disrupted Treg-cell recruitment and inhibited the growth of CRC in mice.(A, B) Flow cytometric analysis of TAMs derived from grafted CRC in CD11b-DTR mice injected with DTmu or DT. (C) CCL20 mRNA levels in grafted CRC in CD11b-DTR mice injected with DTmu or DT (data from 5 mice of each group were pooled together). (D) Lysates of grafted CRC from CD11b-DTR mice injected with DTmu or DT were subjected to western blotting for CCL20 expression. Actin - loading control. (E) Immunofluorescence staining with anti-mouse CCL20 was performed on cryosections of GFP+ CMT93 grafted tumor mass derived from CD11b-DTR mice injected with DTmu or DT for 14 days. (F) Flow cytometric analysis of CCR6 expression for GFP+ CMT93 cells before grafting (left panel), and CCR6 staining on cryosections of GFP+ CMT93 grafted tumor mass derived from CD11b-DTR mice injected with DTmu or DT for 14 days (middle and right panel). (G, H) Number of tumor-infiltrating FoxP3+ Treg-cells in grafted CRC in CD11b-DTR mice injected with DTmu or DT. (I) CRC grafted in CD11b-DTR mice injected with DTmu or DT for 14 days. (J) Tumor weight of CRC grafted in CD11b-DTR mice injected with DTmu or DT for 14 days. Representative data are shown which had been reproduced in 2 independent experiments. Image collected and cropped by CiteAb from the following publication (https://dx.plos.org/10.1371/journal.pone.0019495), licensed under a CC-BY license. Not internally tested by R&D Systems.
Reconstitution Calculator
Preparation and Storage
- 12 months from date of receipt, -20 to -70 °C as supplied.
- 1 month, 2 to 8 °C under sterile conditions after reconstitution.
- 6 months, -20 to -70 °C under sterile conditions after reconstitution.
Background: CCL20/MIP-3 alpha
CCL20, also known as MIP-3 alpha, LARC, and Exodus, is a beta chemokine. Mouse CCL20 cDNA encodes a 97 amino acid precursor protein with a 27 aa putative signal peptide that is predicted to be cleaved to form the 70 aa mature secreted protein. CCL20 is distantly related to other beta chemokines (20‑28% aa sequence identity). Mouse CCL20 shares approximately 71 and 63% amino acid sequence homology with rat and human CCL20, respectively. CCL20 has been shown to be expressed predominantly in lymph nodes, appendix, PBL, fetal liver, fetal lung, and epithelial cells of intestinal tissues. The expression of CCL20 is strongly upregulated by inflammatory signals and downregulated by the anti-inflammatory cytokine IL-10. CCL20 has been shown to be chemotactic for lymphocytes and dendritic cells, and inhibits proliferation of myeloid progenitors in colony formation assays. CCL20 is a functional ligand for CCR6 (previously referred to as GPR-CY4, CKR-L3, or STRL22 orphan receptor), a chemokine receptor that is selectively and highly expressed in human dendritic cells derived from CD34+ cord blood precursors.
- Baba, M. et al. (1997) J. Biol. Chem. 272:14893.
- Hromas, R. et al. (1997) Blood 89:3315.
- Greaves, D. R. et al. (1997) J. Exp. Med. 186: 857.
- Tanaka, Y. et al. (1999) Eur. J. Immunol. 29:633.
Product Datasheets
Citations for Mouse CCL20/MIP-3 alpha Antibody
R&D Systems personnel manually curate a database that contains references using R&D Systems products. The data collected includes not only links to publications in PubMed, but also provides information about sample types, species, and experimental conditions.
7
Citations: Showing 1 - 7
Filter your results:
Filter by:
-
V&gamma4 T cell-derived IL-17A is essential for amplification of inflammatory cascades in ischemic brain tissue after stroke
Authors: L Lu, Y Wang, L Zhou, Y Li, X Zhang, X Hu, S Shi, W He
International immunopharmacology, 2021-05-24;96(0):107678.
Species: Mouse
Sample Types: In Vivo
Applications: Neutralization -
CCL20-CCR6 axis modulated traumatic brain injury-induced visual pathologies
Authors: M Das, X Tang, JY Han, K Mayilsamy, E Foran, MR Biswal, R Tzekov, SS Mohapatra, S Mohapatra
J Neuroinflammation, 2019-05-31;16(1):115.
Species: Mouse
Sample Types: In Vivo
Applications: Neutralization -
Role of S1P/S1PR3 axis in release of CCL20 from human bronchial epithelial cells
Authors: Y Kawa, T Nagano, A Yoshizaki, R Dokuni, M Katsurada, T Terashita, Y Yasuda, K Umezawa, M Yamamoto, H Kamiryo, K Kobayashi, Y Nishimura
PLoS ONE, 2018-09-07;13(9):e0203211.
Species: Mouse
Sample Types: In Vivo
Applications: Neutralization -
Mutations in BALB mitochondrial DNA induce CCL20 up-regulation promoting tumorigenic phenotypes
Authors: James Sligh, Jaroslav Janda, Jana Jandova
Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis
-
Leukocyte attraction by CCL20 and its receptor CCR6 in humans and mice with pneumococcal meningitis.
Authors: Klein M, Brouwer M, Angele B, Geldhoff M, Marquez G, Varona R, Hacker G, Schmetzer H, Hacker H, Hammerschmidt S, van der Ende A, Pfister H, van de Beek D, Koedel U
PLoS ONE, 2014-04-03;9(4):e93057.
Species: Mouse
Sample Types: In Vivo
Applications: Neutralization -
Near-infrared laser adjuvant for influenza vaccine.
Authors: Kashiwagi, Satoshi, Yuan, Jianping, Forbes, Benjamin, Hibert, Mathew L, Lee, Eugene L, Whicher, Laura, Goudie, Calum, Yang, Yuan, Chen, Tao, Edelblute, Beth, Collette, Brian, Edington, Laurel, Trussler, James, Nezivar, Jean, Leblanc, Pierre, Bronson, Roderick, Tsukada, Kosuke, Suematsu, Makoto, Dover, Jeffrey, Brauns, Timothy, Gelfand, Jeffrey, Poznansky, Mark C
PLoS ONE, 2013-12-11;8(12):e82899.
Species: Mouse
Sample Types: Whole Tissue
Applications: IHC -
Contribution of IL-17-producing gamma delta T cells to the efficacy of anticancer chemotherapy.
Authors: Ma Y, Aymeric L, Locher C, Mattarollo SR, Delahaye NF, Pereira P, Boucontet L, Apetoh L, Ghiringhelli F, Casares N, Lasarte JJ, Matsuzaki G, Ikuta K, Ryffel B, Benlagha K, Tesniere A, Ibrahim N, Dechanet-Merville J, Chaput N, Smyth MJ, Kroemer G, Zitvogel L
J. Exp. Med., 2011-03-07;208(3):491-503.
Species: Mouse
Sample Types: Whole Cells
Applications: Neutralization
FAQs
No product specific FAQs exist for this product, however you may
View all Antibody FAQsReviews for Mouse CCL20/MIP-3 alpha Antibody
Average Rating: 5 (Based on 1 Review)
Have you used Mouse CCL20/MIP-3 alpha Antibody?
Submit a review and receive an Amazon gift card.
$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image
Filter by: